BioNexus Gene Lab Balance Sheet (2018-2026)

Reported Financials

BioNexus Gene Lab Quarterly Balance Sheet

Periods 32 quarters

Latest Jun 2026

BioNexus Gene Lab reported total assets of $8.73M and total liabilities of $0.95M for the quarter ended Jun 2026, down 7.4% year over year. This balance sheet covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	1.70M	2.12M	1.84M	1.34M	1.46M	2.12M	1.97M	1.76M	6.15M	-0.22M	5.83M	3.96M	2.67M	2.89M	2.09M	1.54M	1.36M	2.38M	2.40M	1.23M
Cash & Current Investments	1.70M	2.12M	1.84M	1.34M	1.46M	2.12M	1.97M	1.76M	6.15M	-0.22M	5.83M	3.96M	2.67M	2.89M	2.09M	1.54M	1.36M	2.38M	2.40M	1.23M
Receivables - NetNet Receivables	4.19M	3.36M	3.03M	2.83M	2.73M	2.87M	2.53M	2.20M	0.90M	0.80M	0.84M	0.99M	1.43M	1.38M	1.44M	1.85M	1.52M	0.51M	0.08M	0.02M
Receivables - OtherOther Receivables	0.02M	0.08M	0.07M	0.08M	0.07M	0.03M	0.03M	0.05M	0.11M	0.12M	0.11M	0.40M	0.07M	0.20M	0.24M	0.15M	0.10M	0.08M	0.09M	0.11M
Receivables	4.21M	3.44M	3.11M	2.91M	2.80M	2.89M	2.56M	2.24M	1.01M	0.92M	0.95M	1.39M	1.49M	1.58M	1.68M	2.00M	1.62M	0.59M	0.17M	0.12M
Inventory	1.49M	1.52M	1.65M	1.51M	1.10M	0.98M	0.90M	1.17M	1.11M	1.14M	1.08M	1.03M	1.39M	1.39M	1.18M	1.22M	1.01M	0.68M	0.67M	0.65M
Current Assets	7.40M	7.15M	6.60M	5.77M	5.41M	6.02M	5.46M	5.23M	8.27M	8.05M	7.91M	7.84M	7.04M	7.43M	6.54M	6.38M	5.63M	5.45M	5.20M	4.94M
Non-Current Assets
Buildings													1.08M
Property, Plant & Equipment (Net)PP&E (Net)	1.65M	1.63M	1.63M	1.53M	1.44M	1.51M	1.48M	1.40M	1.50M	1.51M	1.47M	1.35M	1.73M	1.52M	1.52M	1.59M	1.57M	1.60M	1.58M	1.54M
Long-Term Investments	0.67M	0.75M	0.91M	1.04M	0.92M	1.15M	1.19M	1.23M	1.55M	1.70M	1.66M	1.71M	1.99M	1.27M	1.21M	1.25M	0.24M	2.03M	2.03M	2.03M
Other Non-Current Assets	1.03M	1.55M	1.24M	0.85M	0.98M	1.51M	1.57M	1.46M	1.44M	4.72M	3.34M	3.21M	2.08M	1.49M	4.01M	1.52M	1.54M	1.55M	1.57M	1.13M
Non-Current Assets	2.36M	2.42M	2.57M	2.60M	2.39M	2.72M	2.73M	2.67M	3.20M	3.35M	3.26M	3.30M	3.96M	3.00M	2.94M	3.04M	1.99M	3.80M	3.84M	3.78M
Assets	9.77M	9.57M	9.18M	8.37M	7.80M	8.74M	8.19M	7.90M	11.47M	11.40M	11.16M	11.14M	11.00M	10.43M	9.48M	9.42M	7.62M	9.25M	9.04M	8.73M
Liabilities
Current Liabilities
Accounts Payables	2.41M	2.01M	1.83M	1.42M	1.28M	1.86M	1.49M	1.82M	1.57M	1.40M	1.43M	0.95M	1.03M	1.50M	1.18M	1.37M	0.18M	0.40M	0.00M	0.61M
Payables	2.41M	2.01M	1.83M	1.42M	1.28M	1.86M	1.49M	1.82M	1.57M	1.40M	1.43M	0.95M	1.03M	1.50M	1.18M	1.37M	0.18M	0.40M	0.00M	0.61M
Accumulated Expenses														0.17M				0.13M	0.11M	0.07M
Other Accumulated Expenses	0.07M	0.07M	0.04M	0.03M	0.04M	0.10M	0.04M	0.03M	0.03M	0.18M	0.21M	0.17M	0.29M	0.28M	0.29M	0.31M	0.38M	0.40M	0.59M	0.61M
Current Leases	0.02M	0.02M	0.02M																0.01M	0.01M
Current Taxes	0.15M	0.10M	0.07M	0.04M					0.00M
Current Deferred Revenue		0.03M	107.00		0.01M	0.02M	0.02M	0.01M	0.01M			0.01M	0.02M	0.10M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M
Total Current Liabilities	2.66M	2.33M	1.98M	1.50M	1.33M	2.00M	1.56M	1.88M	1.64M	1.63M	1.72M	1.40M	1.41M	1.95M	1.56M	1.76M	0.68M	0.52M	0.80M	0.81M
Non-Current Liabilities
Capital Leases	0.02M	0.01M	0.01M																0.05M	0.05M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax		0.03M			0.03M	0.03M	0.03M	0.03M	0.03M	0.01M	0.01M	0.01M	0.01M
Operating Leases	0.03M	0.02M	0.02M	0.02M	0.01M	0.04M	0.04M	0.03M	0.10M	0.10M	0.09M	0.18M	0.18M	0.16M	0.15M	0.14M	0.13M	0.12M	0.10M	0.09M
Total Non-Current Liabilities	0.05M	0.07M	0.06M	0.04M	0.04M	0.07M	0.07M	0.06M	0.13M	0.11M	0.10M	0.19M	0.19M	0.16M	0.15M	0.14M	0.13M	0.12M	0.15M	0.14M
Total Liabilities	2.71M	2.39M	2.05M	1.55M	1.37M	2.08M	2.00M	2.31M	2.15M	1.74M	1.82M	1.59M	1.61M	2.11M	1.71M	1.90M	0.80M	0.64M	0.95M	0.95M
Shareholder's Equity
Common Equity	7.05M	7.18M	7.13M	6.82M	6.42M	6.67M	6.19M	5.59M	9.32M	9.66M	9.34M	9.55M	9.39M	8.32M	7.77M	7.52M	6.82M	8.61M	8.09M	7.78M
Liabilities and Shareholders Equity	9.77M	9.57M	9.18M	8.37M	7.80M	8.74M	8.19M	7.90M	11.47M	11.40M	11.16M	11.14M	11.00M	10.43M	9.48M	9.42M	7.62M	9.25M	9.04M	8.73M
Retained Earnings	1.42M	1.51M	1.53M	1.39M	1.31M	1.16M	1.09M	0.83M	-1.78M	-1.84M	-1.95M	-1.75M	-3.09M	-3.44M	-4.07M	-4.68M	-5.39M	-6.43M	-6.97M	-7.26M

BioNexus Gene Lab Balance Sheet API

Pull BioNexus Gene Lab's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BGLC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "BGLC", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=BGLC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

BioNexus Gene Lab BGLC Balance Sheet (2018-2026)

BioNexus Gene Lab Quarterly Balance Sheet

BioNexus Gene Lab Balance Sheet API

Create an account

Sign In

Reset Password